Assessment of drug utilization pattern of antidiabetic drugs in type-2 diabetes outpatient of a tertiary care teaching hospital western Rajasthan

S. Tanwar, A. Acharya, Najmul Hasan
{"title":"Assessment of drug utilization pattern of antidiabetic drugs in type-2 diabetes outpatient of a tertiary care teaching hospital western Rajasthan","authors":"S. Tanwar, A. Acharya, Najmul Hasan","doi":"10.18203/2319-2003.IJBCP20211017","DOIUrl":null,"url":null,"abstract":"Background: Glycemic control remains the major therapeutic objective for prevention of target organ damage and other complications arising from diabetes. Poor glycemic control in diabetes mellitus can be prevented by using rational use of oral hypoglycemic agents (OHA). Rational use of the drugs in populations can be effectively evaluated using drug utilization studies. Methods: The present study was conducted in the outpatient departments of General Medicine at Sardar Patel Medical College associated group of PBM Hospital, a tertiary care teaching hospital. It was a cross sectional prospective study carried out over a period of four months from September 2020 to January 2020. Patients were enrolled on the basis of inclusion and exclusion criteria. Results: Total 300 patient prescription patterns were studied, out of which 58.33% were males and 41.66% were females. Most of the patients were in the age group of 51-60 years. Average number of anti-diabetic drugs per prescription was found to be 1.99. biguanides was the most commonly prescribed drug (97%) as mono therapy and combination therapy followed by sulfonylureas (65.6%), DPP 4 inhibitors (24%) Majority of the patients (66%) were on multidrug therapy. Conclusions: Metformin was the most frequently prescribed drug in diabetes. Prescription by Brand name is a matter of concern. Overall, monotherapy was found to be predominant over combination therapy. There was no significant increase in the prescribing of newer oral antidiabetic agents like GLP-1receptor inhibitors and DPP-4 inhibitors. glimepride + metformin combination was the most commonly prescribed combination.","PeriodicalId":13898,"journal":{"name":"International journal of basic and clinical pharmacology","volume":"93 1","pages":"368"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of basic and clinical pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18203/2319-2003.IJBCP20211017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Glycemic control remains the major therapeutic objective for prevention of target organ damage and other complications arising from diabetes. Poor glycemic control in diabetes mellitus can be prevented by using rational use of oral hypoglycemic agents (OHA). Rational use of the drugs in populations can be effectively evaluated using drug utilization studies. Methods: The present study was conducted in the outpatient departments of General Medicine at Sardar Patel Medical College associated group of PBM Hospital, a tertiary care teaching hospital. It was a cross sectional prospective study carried out over a period of four months from September 2020 to January 2020. Patients were enrolled on the basis of inclusion and exclusion criteria. Results: Total 300 patient prescription patterns were studied, out of which 58.33% were males and 41.66% were females. Most of the patients were in the age group of 51-60 years. Average number of anti-diabetic drugs per prescription was found to be 1.99. biguanides was the most commonly prescribed drug (97%) as mono therapy and combination therapy followed by sulfonylureas (65.6%), DPP 4 inhibitors (24%) Majority of the patients (66%) were on multidrug therapy. Conclusions: Metformin was the most frequently prescribed drug in diabetes. Prescription by Brand name is a matter of concern. Overall, monotherapy was found to be predominant over combination therapy. There was no significant increase in the prescribing of newer oral antidiabetic agents like GLP-1receptor inhibitors and DPP-4 inhibitors. glimepride + metformin combination was the most commonly prescribed combination.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
拉贾斯坦邦西部某三级护理教学医院2型糖尿病门诊患者降糖药使用模式评价
背景:血糖控制仍然是预防糖尿病引起的靶器官损伤和其他并发症的主要治疗目标。合理使用口服降糖药(OHA)可预防糖尿病患者血糖控制不良。药物利用研究可以有效地评价人群中药物的合理使用情况。方法:本研究在萨达帕特尔医学院附属三级教学医院PBM医院普通内科门诊进行。这是一项横断面前瞻性研究,从2020年9月到2020年1月,为期4个月。患者根据纳入和排除标准入组。结果:共研究300例患者的处方模式,其中男性占58.33%,女性占41.66%。大多数患者年龄在51 ~ 60岁之间。每张处方的平均抗糖尿病药物数量为1.99。单药治疗以双胍类药物最多(97%),其次为磺脲类药物(65.6%)、dpp4抑制剂(24%)。多数患者(66%)采用多药治疗。结论:二甲双胍是糖尿病患者最常用的处方药。品牌处方是一个值得关注的问题。总体而言,单药治疗优于联合治疗。新的口服降糖药如glp -1受体抑制剂和DPP-4抑制剂的处方没有显著增加。Glimepride +二甲双胍组合是最常用的处方组合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment of KaraShieldTM properties in supporting the immune health of healthy subjects: a randomized, parallel, double-blind, placebo-controlled clinical study Knowledge attitude and practices of drug promotional literature: a clinician’s perspective Evaluation of β-blockers dosage regimen rationality in heart failure patients Perceptions of undergraduate medical students of old traditional and new CBME curriculum about pharmacovigilance and adverse drug reactions reporting at a tertiary care teaching hospital: a comparative study Comparison of efficacy of azilsartan with olmesartan in patients of hypertension: randomized controlled trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1